ATS 2019 Virtual Final Program

3:55 Cilia Dysfunction in Patients with Congenital Heart Disease C. Lo, PhD, Pittsburgh, PA CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 MOC Points Available: 2 B86 PULMONARY REHABILITATION IN NON-COPD CHRONIC RESPIRATORY CONDITIONS Assemblies on Pulmonary Rehabilitation; Clinical Problems; Nursing 2:15 p.m. - 4:15 p.m. OMNI DALLAS DOWNTOWN Trinity Ballroom 4/8 (Level 3) Target Audience Doctors, nurses, allied health professionals, researchers involved in the care of people with non-COPD chronic respiratory disease Objectives At the conclusion of this session, the participant will be able to: • understand the role of pulmonary rehabilitation in the management Interstitial Lung Disease, asthma, pulmonary arterial hypertension and lung transplantation; • more appropriately refer patients with Interstitial Lung Disease, asthma, pulmonary arterial hypertension and lung transplantation to pulmonary rehabilitation; • understand the educational needs of people with non-COPD chronic respiratory disease. The evidence for pulmonary rehabilitation in some of the most common non-COPD chronic respiratory diseases as well as strategies to enable the tailoring of the education component of pulmonary rehabilitation for these diseases will be presented at this scientific symposium. Chairing: C. Nolan, PT, BSc, MSc, PhD, London, United Kingdom R. Goldstein, MD, Toronto, Canada 2:15 A Patient's Perspective M. Williams, Plano, TX 2:20 Pulmonary Rehabilitation for Interstitial Lung Disease: Where We Are Now and Where We Are Going A.E. Holland, PhD, Melbourne, Australia 2:40 Pulmonary Hypertension: To Do PR or Not to Do PR? C.L. Rochester, MD, New Haven, CT 3:00 Is There a Role for Pulmonary Rehabilitation in the Management of Lung Transplantation? D. Langer, PhD, PT, Leuven, Belgium 3:20 Pulmonary Rehabilitation in the Management of Asthma R.H. Crouch, DPT, MS, PT, Chapel Hill, NC 3:40 Tailoring Education in Pulmonary Rehabilitation for Non-COPD Respiratory Disease S.C. Lareau, RN, MS, ATSF, Aurora, CO 4:00 Panel Discussion BASIC • TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 B87 CROSSTALK BETWEEN AIRWAY EPITHELIUM AND TYPE 2 IMMUNITY IN ASTHMA Assembly on Allergy, Immunology and Inflammation 2:15 p.m. - 4:15 p.m. KBHCCD Ballroom D One (Level 3) Target Audience Pulmonary physicians and scientists Objectives At the conclusion of this session, the participant will be able to: • define the pathways whereby the airway epithelium senses and responds to aeroallergens in asthma; • define the mechanisms driving pathologic type 2 immunity in asthma; • identify areas of uncertainty in type 2 high asthma biology. This Scientific Symposium will cover the biologic mechanisms regulating type 2 inflammation in asthma. Experts in the field will present our current state of knowledge on type 2 high asthma, focusing on pathologic crosstalk between the airway epithelium and the immune system. The objective of this symposium is to define the outstanding questions in type 2 high asthma and propose potential new therapeutic approaches. Chairing: R.A. Rahimi, MD, PhD, Boston, MA D.C. Newcomb, PhD, Nashville, TN J.V. Fahy, MD, San Francisco, CA 2:15 Regulation of Allergic Immunity in Early Life C. Lloyd, PhD, London, United Kingdom 2:35 Sex Steroids in the Regulation of Allergic Asthma D.C. Newcomb, PhD, Nashville, TN 2:55 Spontaneous Protein Crystallization in Asthma as a New Drug Target B. Lambrecht, MD, PhD, Ghent, Belgium 3:15 Focal Type 2 Airway Niches in Asthma J.V. Fahy, MD, San Francisco, CA 3:35 Trafficking and Function of Lung-Resident and Circulating Memory Th2 Cells in Allergic Asthma R.A. Rahimi, MD, PhD, Boston, MA 3:55 Lung Dendritic Cells and the Resident Memory Response in Allergic Asthma A.I. Sperling, PhD, ATSF, Chicago, IL This session and the International Conference are supported by educational grants from Genentech, Inc., Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests. ATS 2019 • Dallas, TX MONDAY • MAY 20 201 MONDAY AFTERNOON